Global Epithelial Cell Culture Media Industry to 2028 – Thriving Biopharmaceutical Industries in Different Countries Presenting Opportunities

DUBLIN, July 02, 2021– (COMMERCIAL THREAD)–The “Epithelial Cell Culture Media Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type and End User” report was added to offer.

Epithelial Cell Culture Media Market Expected to Reach US $ 303,040.33 Thousand by 2028 vs. $ 128,155.95 Thousand in 2020; it is estimated to increase at a CAGR of 11.36% over the period 2020-2028.

The growth of the market is mainly attributed to key factors such as the increasing applications of epithelial cells and increasing funding of epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines is hampering the growth of the market.

Epithelial cells isolated from tracheal, bronchial, distal respiratory tract, mammary, prostatic, vaginal, cervical and renal tissues, among others, mimic the physiological state of cells in vivo. These cells are invaluable in biological research for understanding how living systems work. Cervical epithelial cells provide an in vitro model for studying physiological processes associated with diseases such as cervical cancer, cervical polyps, and human papillomavirus (HPV) disease. The 3D model epithelial cells are used in disease modeling, molecule uptake, toxicity studies, and drug discovery, among others. For several decades, cellular tests have been widely used in drug discovery. 2D models provide valuable information on early biological responses and are suitable for high throughput drug screening, but they offer poor predictive capabilities. In addition, epithelial cell lines are used in studies of drug transport processes. Epithelial cell drug transport studies can be easily performed under controlled conditions and generate important information.

Along with the increasing applications of epithelial cells, the demand for media necessary for culturing these cell lines is also increasing, which is driving the growth of the epithelial cell culture media market.

Based on the product type, the epithelial cell culture media market is segmented into human mammary epithelial cells, bronchial / tracheal epithelial cells, and renal epithelial cells. By end user, the market is segmented into biopharmaceutical companies, academic and research laboratories, and others. The biopharmaceutical companies segment held the largest share of the market in 2020. Biopharmaceuticals have been the fastest growing area of ​​the pharmaceutical industry in recent years, with over 200 treatments approved and hundreds more in progress. development, while the pharmaceutical industry as a whole has struggled with single-digit growth, tighter pipelines and pressure from an increasingly aggressive generics company. This is expected to promote the growth of the market during the forecast period.

Reasons to buy

  • Gain and reduce the time required to conduct entry-level research by identifying the growth, size, leading players and segments of the Epithelial Cell Culture Media market.

  • Highlights key business priorities to help companies realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global Epithelial Cell Culture Media Market, thereby enabling value chain players to develop effective long-term strategies.

  • Develop / modify business expansion plans using a substantial growth offering in developed and emerging markets.

  • Take an in-depth look at the global market trends and outlook associated with the factors driving the market, as well as those hindering it.

  • Improve the decision-making process by understanding the strategies that underpin security with respect to customer products, segmentation, pricing, and distribution.

Market dynamics




Future trends

Companies mentioned

For more information on this report, visit

View the source version on

Laura Wood, Senior Press Director

For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

Previous US creates 850,000 jobs as economy expands earnings
Next US judges Thomas and Gorsuch question defamation protections for media

No Comment

Leave a reply

Your email address will not be published.